Home
News
- 1 TDOC stock price experienced nearly mixed market sentiments ahead of its Q2 2023 report.
- 2 In monthly price analysis, TDOC share price showed a bearish trend, while its weekly analysis showed a bullish outlook.
Recently, Teladoc Health (TDOC) stock price noted increased bears dominance that supported its price to reach near to its 100-day moving average. However, earlier this week, its partnership with Microsoft (MSFT.O) to use its artificial intelligence (AI) services to automate clinical documentation on the telehealth platform, raised the TDOC stock price to nearly $25.50.
TDOC Stock Price Analysis
Teladoc Health (TDOC) stock price opened at $25.59, gave high at $26.18 while low was at $25.00, on July 19, 2023, Wednesday’s trading session. The closing price noted by TDOC share was at $25.26 while the stock lost $0.09 and dropped 0.36%. However, in its weekly trading session the stock price showed a bullish trend with 0.40% price gain, as per the data sourced from TradingView, a web-based social network for traders.
As shown in the above price chart, the pre-market price of TDOC stock is resting at $25.25, which is slightly down from the stock’s last closing price. As the current market sentiments are indicating, bears are showing their dominance in the market due to which, the RSI of theTDOC share price further started showing a downside trend.
The analysts are also offering their 1-year price target which is at $29.75 and up over 17% from the recent closing price of TDOC stock. Their maximum estimate is showing at $40.00 while the minimum estimate is at $23.00.
The Fundamentals of Teladoc Health
Teladoc Health Inc. (NYSE: TDOC), a healthcare company, has a market cap of $4.13 Billion. On April 26, 2023, the company released its Q1 2023 report which stated its net income to be negative $69.23 Million. TDOC price-to-sales ratio is 1.67 and it has an Enterprise Value to EBITDA ratio of 93.08.
The healthcare company reported its earnings per share (EPS) for Q1 2023 to be negative $0.42 whereas the estimation was negative $0.48, which accounts for a 13.24% surprise. The revenue for the same period amounts to $629.24 Million, despite the estimated figure of $619.30 Million. For the upcoming Q2 2023, the estimated EPS is negative $0.41, and revenue is expected to reach $649.20 Million.
The revenue of Teladoc Health Inc. last year reached $2.41 Billion, out of which $1.37 Billion came from its highest performing source at the moment, Teladoc Health Integrated Care. Moreover, the U.S. gave the greatest contribution to the company’s revenue which brought Teladoc Health Inc. $2.10 Billion last year.
Disclaimer
The views and opinions stated by the author, or any people named in this article, are for informational ideas only and do not establish financial, investment, or other advice. Investing in or trading crypto or stock comes with a risk of financial loss.
Andrew is a blockchain developer who developed his interest in cryptocurrencies while pursuing his post-graduation major in blockchain development. He is a keen observer of details and shares his passion for writing, along with coding. His backend knowledge about blockchain helps him give a unique perspective to his writing skills, and a reliable craft at explaining the concepts such as blockchain programming, languages and token minting. He also frequently shares technical details and performance indicators of ICOs and IDOs.
